• Something wrong with this record ?

Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Oncological outcomes

M. Hruda, H. Robova, L. Rob, MJ. Halaska, J. Drozenova, T. Pichlik, H. Malikova

. 2021 ; 163 (1) : 100-104. [pub] 20210728

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22012143

INTRODUCTION: The standard procedure in cervical cancer is radical hysterectomy (RH) and pelvic lymphadenectomy (PLND). Because of the increasing age of women at childbirth, fertility becomes a major challenge. We present 20 years of experience with two-step less radical fertility-sparing surgery in women with IA1, LVSI positive, IA2 and IB1 (<2 cm, infiltration less than half of stromal invasions. MATERIALS AND METHOD: Preoperative workout consisted of histopathological diagnosis and magnetic resonance imaging along with ultrasonographic volumetry. We then performed laparoscopic sentinel lymph node mapping (SLNM) with frozen section (FS) followed by PLND and "selective parametrectomy" (removal of afferent lymphatic channels from the paracervix) in case of a negative result. If verified by definitive histopathology, patients were treated by simple trachelectomy (IB1) or large cone (IA1/IA2) biopsy 1 week after primary surgery. RESULTS: From 1999 to 2018, 91 women were enrolled in the study (median age 29.1 years, range 21-40). Of these 91 women, 51 (56.0%) were nulliparous. The detection rate of SLNs was 100% per patient and the specific side detection rate 96.7%. Positive lymph nodes were diagnosed in nine cases (9.8%). These women then underwent RH. Fertility was spared in 80 women but 4 recurred locally (5.0%). The mortality rate was 0.0%. The median follow-up was 149 months. CONCLUSION: Less radical fertility-sparing surgery with SLNM is safe in cervical cancers <2 cm at the largest diameter and infiltrating less than half of the cervical stroma. The recurrence rate is acceptable with no mortality. Morbidity with this procedure is low. Extended and accurate follow-up is necessary and human papillomavirus - high risk (HPV-HR tests seem to be useful in such follow-up assessment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012143
003      
CZ-PrNML
005      
20220506125923.0
007      
ta
008      
220425s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ygyno.2021.07.031 $2 doi
035    __
$a (PubMed)34330536
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hruda, Martin $u 3(rd) Medical Faculty, Charles University, Department of Obstetrics & Gynaecology, Czech Republic; Faculty of Medicine in Plzeň, Charles University, Department of Obstetrics & Gynaecology, Czech Republic
245    10
$a Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Oncological outcomes / $c M. Hruda, H. Robova, L. Rob, MJ. Halaska, J. Drozenova, T. Pichlik, H. Malikova
520    9_
$a INTRODUCTION: The standard procedure in cervical cancer is radical hysterectomy (RH) and pelvic lymphadenectomy (PLND). Because of the increasing age of women at childbirth, fertility becomes a major challenge. We present 20 years of experience with two-step less radical fertility-sparing surgery in women with IA1, LVSI positive, IA2 and IB1 (<2 cm, infiltration less than half of stromal invasions. MATERIALS AND METHOD: Preoperative workout consisted of histopathological diagnosis and magnetic resonance imaging along with ultrasonographic volumetry. We then performed laparoscopic sentinel lymph node mapping (SLNM) with frozen section (FS) followed by PLND and "selective parametrectomy" (removal of afferent lymphatic channels from the paracervix) in case of a negative result. If verified by definitive histopathology, patients were treated by simple trachelectomy (IB1) or large cone (IA1/IA2) biopsy 1 week after primary surgery. RESULTS: From 1999 to 2018, 91 women were enrolled in the study (median age 29.1 years, range 21-40). Of these 91 women, 51 (56.0%) were nulliparous. The detection rate of SLNs was 100% per patient and the specific side detection rate 96.7%. Positive lymph nodes were diagnosed in nine cases (9.8%). These women then underwent RH. Fertility was spared in 80 women but 4 recurred locally (5.0%). The mortality rate was 0.0%. The median follow-up was 149 months. CONCLUSION: Less radical fertility-sparing surgery with SLNM is safe in cervical cancers <2 cm at the largest diameter and infiltrating less than half of the cervical stroma. The recurrence rate is acceptable with no mortality. Morbidity with this procedure is low. Extended and accurate follow-up is necessary and human papillomavirus - high risk (HPV-HR tests seem to be useful in such follow-up assessment.
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    12
$a zachování plodnosti $7 D059247
650    _2
$a lidé $7 D006801
650    12
$a hysterektomie $7 D007044
650    12
$a lymfadenektomie $7 D008197
650    _2
$a lokální recidiva nádoru $x epidemiologie $7 D009364
650    _2
$a staging nádorů $7 D009367
650    _2
$a prospektivní studie $7 D011446
650    _2
$a trachelektomie $7 D000069339
650    _2
$a nádory děložního čípku $x mortalita $x patologie $x chirurgie $7 D002583
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Robova, Helena $u 3(rd) Medical Faculty, Charles University, Department of Obstetrics & Gynaecology, Czech Republic. Electronic address: helena.robova@fnkv.cz
700    1_
$a Rob, Lukas $u 3(rd) Medical Faculty, Charles University, Department of Obstetrics & Gynaecology, Czech Republic
700    1_
$a Halaska, Michael J $u 3(rd) Medical Faculty, Charles University, Department of Obstetrics & Gynaecology, Czech Republic
700    1_
$a Drozenova, Jana $u 3(rd) Medical Faculty, Charles University, Department of Pathology, Czech Republic
700    1_
$a Pichlik, Tomas $u 3(rd) Medical Faculty, Charles University, Department of Obstetrics & Gynaecology, Czech Republic
700    1_
$a Malikova, Hana $u 3(rd) Medical Faculty, Charles University, Department of Radiology, Czech Republic
773    0_
$w MED00001958 $t Gynecologic oncology $x 1095-6859 $g Roč. 163, č. 1 (2021), s. 100-104
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34330536 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506125915 $b ABA008
999    __
$a ok $b bmc $g 1789647 $s 1163344
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 163 $c 1 $d 100-104 $e 20210728 $i 1095-6859 $m Gynecologic oncology $n Gynecol Oncol $x MED00001958
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Archiving options